The concomitant use of OXYCONTIN and CYP3A4 inducers can reduce the plasma focus of oxycodone [see CLINICAL PHARMACOLOGY], leading to diminished efficacy or onset of a withdrawal syndrome in sufferers who definitely have formulated Bodily dependence to oxycodone [see WARNINGS AND PRECAUTIONS]."However, some pharmacies may well not give facts more t